Related Experiment Video
Updated: Aug 31, 2026

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
DNA repair: enzymatic mechanisms and relevance to drug response
1Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill 27599-7260, USA.
Abstract:
A number of chemotherapeutic agents, such as platinum drugs, nitrogen mustards, and chloroethylnitrosoureas, act by forming bifunctional DNA adducts. It is likely that abortive attempts to replicate and/or repair the damaged DNA cause chromosome aberrations and breakage, leading to cell death. Any substantial increase in cellular capacity to repair damaged DNA may result in resistance to chemotherapeutic agents. In this review, we examine the types of DNA adducts formed by the major classes of chemotherapeutic agents, the enzymatic pathways that play a role in the repair of those adducts, the evidence that DNA repair is enhanced in drug-resistant cell lines and tumors, and strategies for utilizing selective inhibition of DNA repair to overcome resistance.
Insights
Chemotherapy drugs create DNA adducts, leading to cell death. Enhanced DNA repair mechanisms can cause drug resistance, but inhibiting these pathways may restore treatment effectiveness.
Area of Science:
- Molecular Biology
- Genetics
- Pharmacology
Background:
- Chemotherapeutic agents like platinum drugs, nitrogen mustards, and chloroethylnitrosoureas induce cell death by forming bifunctional DNA adducts.
- Replication or repair of damaged DNA can lead to chromosome aberrations and cell death.
- Increased cellular DNA repair capacity is linked to resistance against chemotherapeutic agents.
Purpose of the Study:
- To review the types of DNA adducts formed by major chemotherapeutic agents.
- To examine the enzymatic pathways involved in repairing these DNA adducts.
- To explore the link between enhanced DNA repair and drug resistance.
- To discuss strategies for overcoming resistance by inhibiting DNA repair.
Main Methods:
- Literature review of DNA adduct formation by chemotherapeutic agents.
- Analysis of enzymatic DNA repair pathways.
- Examination of evidence for enhanced DNA repair in resistant cells and tumors.
- Review of therapeutic strategies targeting DNA repair inhibition.
Main Results:
- Chemotherapeutic agents form various bifunctional DNA adducts.
- Specific enzymatic pathways are responsible for repairing these adducts.
- Drug-resistant cell lines and tumors exhibit enhanced DNA repair capabilities.
- Inhibiting DNA repair pathways shows potential for overcoming drug resistance.
Conclusions:
- DNA adduct formation is a key mechanism of chemotherapy.
- Enhanced DNA repair is a significant factor in chemotherapeutic resistance.
- Targeting DNA repair pathways offers a promising strategy to improve cancer treatment efficacy.
Related Concept Videos
Nucleotide Excision Repair
Overview of DNA Repair
Chemically...
Long-patch Base Excision Repair
Nucleotide Excision Repair
Overview of DNA Repair
Chemically...
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...

